Poly(L-lactic acid)/polyethylenimine nanoparticles as plasmid DNA carriers.

Area of Science:

• Biomaterials Science
• Nanotechnology
• Gene Therapy

Background:

• Non-viral vectors like liposomes, polycations, and nanoparticles are crucial for gene delivery.
• Developing safe and effective gene carriers remains a key challenge in gene therapy.

Purpose of the Study:

• To prepare and characterize biodegradable poly(L-lactic acid) (PLA)/polyethylenimine (PEI) nanoparticles for gene delivery.
• To evaluate the transfection efficiency and cytotoxicity of these novel nanoparticles.

Main Methods:

• PLA/PEI nanoparticles were synthesized using a double emulsion-solvent evaporation technique.
• Plasmid DNA (pDNA) binding capacity was assessed via agarose gel electrophoresis.
• Transfection efficiency was quantified using beta-galactosidase assays and flow cytometry in HEK 293 and HeLa cells.

Main Results:

• The PLA/PEI 25K system exhibited higher transfection efficiency compared to PLA/PEI 0.8K and PLA/PEI 750K systems.
• Optimal transfection efficiency was achieved at a PLA/PEI nanoparticle to pDNA ratio of 60:1 (w/w).
• Cytotoxicity was dose-dependent but comparable to commercial Lipofectin.

Conclusions:

• PLA/PEI nanoparticles represent a viable biodegradable non-viral gene delivery system.
• The molecular weight of PEI and the nanoparticle-to-pDNA ratio significantly influence transfection efficiency.
• These nanoparticles hold potential for future gene therapy applications.